カテゴリ： 世界, 医療/バイオ, Market Monitor Global

血漿由来医療製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他

■ 英語タイトル：Plasma-derived Medical Product Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY8568）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY8568
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品＆ヘルスケア
■ ページ数：103
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[血漿由来医療製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の血漿由来医療製品市場規模と予測を収録しています。・世界の血漿由来医療製品市場：売上、2018年-2023年、2024年-2029年
・世界の血漿由来医療製品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の血漿由来医療製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫グロブリン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

血漿由来医療製品のグローバル主要企業は、Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、血漿由来医療製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の血漿由来医療製品市場：タイプ別、2018年-2023年、2024年-2029年
世界の血漿由来医療製品市場：タイプ別市場シェア、2022年
・免疫グロブリン、凝固因子、アルブミン、その他

世界の血漿由来医療製品市場：用途別、2018年-2023年、2024年-2029年
世界の血漿由来医療製品市場：用途別市場シェア、2022年
・病院、薬局、その他

世界の血漿由来医療製品市場：地域・国別、2018年-2023年、2024年-2029年
世界の血漿由来医療製品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における血漿由来医療製品のグローバル売上、2018年-2023年
・主要企業における血漿由来医療製品のグローバル売上シェア、2022年
・主要企業における血漿由来医療製品のグローバル販売量、2018年-2023年
・主要企業における血漿由来医療製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics

*************************************************************

・調査・分析レポートの概要
血漿由来医療製品市場の定義
市場セグメント
世界の血漿由来医療製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の血漿由来医療製品市場規模
世界の血漿由来医療製品市場規模：2022年 VS 2029年
世界の血漿由来医療製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの血漿由来医療製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の血漿由来医療製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫グロブリン、凝固因子、アルブミン、その他
血漿由来医療製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局、その他
血漿由来医療製品の用途別グローバル売上・予測

・地域別市場分析
地域別血漿由来医療製品市場規模 2022年と2029年
地域別血漿由来医療製品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics
...

Human blood plasma is nature’s raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation
This report aims to provide a comprehensive presentation of the global market for Plasma-derived Medical Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plasma-derived Medical Product. This report contains market size and forecasts of Plasma-derived Medical Product in global, including the following market information:
Global Plasma-derived Medical Product Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Plasma-derived Medical Product market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Immune Globulin Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Plasma-derived Medical Product include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Plasma-derived Medical Product companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Plasma-derived Medical Product Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Plasma-derived Medical Product Market Segment Percentages, by Type, 2022 (%)
Immune Globulin
Coagulation Factor
Albumin
Others
Global Plasma-derived Medical Product Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Plasma-derived Medical Product Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Others
Global Plasma-derived Medical Product Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Plasma-derived Medical Product Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Plasma-derived Medical Product revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Plasma-derived Medical Product revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Plasma-derived Medical Product, market overview.
Chapter 2: Global Plasma-derived Medical Product market size in revenue.
Chapter 3: Detailed analysis of Plasma-derived Medical Product company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Plasma-derived Medical Product in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Plasma-derived Medical Product Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Plasma-derived Medical Product Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Plasma-derived Medical Product Overall Market Size
2.1 Global Plasma-derived Medical Product Market Size: 2022 VS 2029
2.2 Global Plasma-derived Medical Product Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Plasma-derived Medical Product Players in Global Market
3.2 Top Global Plasma-derived Medical Product Companies Ranked by Revenue
3.3 Global Plasma-derived Medical Product Revenue by Companies
3.4 Top 3 and Top 5 Plasma-derived Medical Product Companies in Global Market, by Revenue in 2022
3.5 Global Companies Plasma-derived Medical Product Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma-derived Medical Product Players in Global Market
3.6.1 List of Global Tier 1 Plasma-derived Medical Product Companies
3.6.2 List of Global Tier 2 and Tier 3 Plasma-derived Medical Product Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Plasma-derived Medical Product Market Size Markets, 2022 & 2029
4.1.2 Immune Globulin
4.1.3 Coagulation Factor
4.1.4 Albumin
4.1.5 Others
4.2 By Type – Global Plasma-derived Medical Product Revenue & Forecasts
4.2.1 By Type – Global Plasma-derived Medical Product Revenue, 2018-2023
4.2.2 By Type – Global Plasma-derived Medical Product Revenue, 2024-2029
4.2.3 By Type – Global Plasma-derived Medical Product Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Plasma-derived Medical Product Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application – Global Plasma-derived Medical Product Revenue & Forecasts
5.2.1 By Application – Global Plasma-derived Medical Product Revenue, 2018-2023
5.2.2 By Application – Global Plasma-derived Medical Product Revenue, 2024-2029
5.2.3 By Application – Global Plasma-derived Medical Product Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Plasma-derived Medical Product Market Size, 2022 & 2029
6.2 By Region – Global Plasma-derived Medical Product Revenue & Forecasts
6.2.1 By Region – Global Plasma-derived Medical Product Revenue, 2018-2023
6.2.2 By Region – Global Plasma-derived Medical Product Revenue, 2024-2029
6.2.3 By Region – Global Plasma-derived Medical Product Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Plasma-derived Medical Product Revenue, 2018-2029
6.3.2 US Plasma-derived Medical Product Market Size, 2018-2029
6.3.3 Canada Plasma-derived Medical Product Market Size, 2018-2029
6.3.4 Mexico Plasma-derived Medical Product Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Plasma-derived Medical Product Revenue, 2018-2029
6.4.2 Germany Plasma-derived Medical Product Market Size, 2018-2029
6.4.3 France Plasma-derived Medical Product Market Size, 2018-2029
6.4.4 U.K. Plasma-derived Medical Product Market Size, 2018-2029
6.4.5 Italy Plasma-derived Medical Product Market Size, 2018-2029
6.4.6 Russia Plasma-derived Medical Product Market Size, 2018-2029
6.4.7 Nordic Countries Plasma-derived Medical Product Market Size, 2018-2029
6.4.8 Benelux Plasma-derived Medical Product Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Plasma-derived Medical Product Revenue, 2018-2029
6.5.2 China Plasma-derived Medical Product Market Size, 2018-2029
6.5.3 Japan Plasma-derived Medical Product Market Size, 2018-2029
6.5.4 South Korea Plasma-derived Medical Product Market Size, 2018-2029
6.5.5 Southeast Asia Plasma-derived Medical Product Market Size, 2018-2029
6.5.6 India Plasma-derived Medical Product Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Plasma-derived Medical Product Revenue, 2018-2029
6.6.2 Brazil Plasma-derived Medical Product Market Size, 2018-2029
6.6.3 Argentina Plasma-derived Medical Product Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Plasma-derived Medical Product Revenue, 2018-2029
6.7.2 Turkey Plasma-derived Medical Product Market Size, 2018-2029
6.7.3 Israel Plasma-derived Medical Product Market Size, 2018-2029
6.7.4 Saudi Arabia Plasma-derived Medical Product Market Size, 2018-2029
6.7.5 UAE Plasma-derived Medical Product Market Size, 2018-2029
7 Plasma-derived Medical Product Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Plasma-derived Medical Product Major Product Offerings
7.1.4 Takeda Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Plasma-derived Medical Product Major Product Offerings
7.2.4 CSL Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Plasma-derived Medical Product Major Product Offerings
7.3.4 Grifols Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 Octapharma
7.4.1 Octapharma Company Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Plasma-derived Medical Product Major Product Offerings
7.4.4 Octapharma Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.4.5 Octapharma Key News & Latest Developments
7.5 Kedrion
7.5.1 Kedrion Company Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Plasma-derived Medical Product Major Product Offerings
7.5.4 Kedrion Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.5.5 Kedrion Key News & Latest Developments
7.6 LFB Group
7.6.1 LFB Group Company Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Plasma-derived Medical Product Major Product Offerings
7.6.4 LFB Group Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.6.5 LFB Group Key News & Latest Developments
7.7 Biotest
7.7.1 Biotest Company Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Plasma-derived Medical Product Major Product Offerings
7.7.4 Biotest Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.7.5 Biotest Key News & Latest Developments
7.8 BPL
7.8.1 BPL Company Summary
7.8.2 BPL Business Overview
7.8.3 BPL Plasma-derived Medical Product Major Product Offerings
7.8.4 BPL Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.8.5 BPL Key News & Latest Developments
7.9 RAAS
7.9.1 RAAS Company Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Plasma-derived Medical Product Major Product Offerings
7.9.4 RAAS Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.9.5 RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Plasma-derived Medical Product Major Product Offerings
7.10.4 CBPO Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.10.5 CBPO Key News & Latest Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Company Summary
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Plasma-derived Medical Product Major Product Offerings
7.11.4 Hualan Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.11.5 Hualan Bio Key News & Latest Developments
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Summary
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Plasma-derived Medical Product Major Product Offerings
7.12.4 Tiantan Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.12.5 Tiantan Bio Key News & Latest Developments
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Summary
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Plasma-derived Medical Product Major Product Offerings
7.13.4 Shuanglin Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.13.5 Shuanglin Bio Key News & Latest Developments
7.14 Boya Bio
7.14.1 Boya Bio Company Summary
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Plasma-derived Medical Product Major Product Offerings
7.14.4 Boya Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.14.5 Boya Bio Key News & Latest Developments
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Summary
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Plasma-derived Medical Product Major Product Offerings
7.15.4 Yuanda Shuyang Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.15.5 Yuanda Shuyang Key News & Latest Developments
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Summary
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Plasma-derived Medical Product Major Product Offerings
7.16.4 Weiguang Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.16.5 Weiguang Bio Key News & Latest Developments
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Summary
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Plasma-derived Medical Product Major Product Offerings
7.17.4 Nanyue Bio Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.17.5 Nanyue Bio Key News & Latest Developments
7.18 KM Biologics
7.18.1 KM Biologics Company Summary
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Plasma-derived Medical Product Major Product Offerings
7.18.4 KM Biologics Plasma-derived Medical Product Revenue in Global Market (2018-2023)
7.18.5 KM Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血漿分画技術のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • ヒト血漿分画のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
  • 血漿タンパク質製品のグローバル市場展望 2023年-2029年：アルブミン、免疫グロブリン、凝固因子、その他
  • 血漿分画技術の世界市場2023年：アルブミン、免疫グロブリン、凝固因子、その他
  • 血漿分画の世界市場2023年：免疫グロブリン、凝固因子、アルブミン、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY8568 )"血漿由来医療製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他" (英文：Plasma-derived Medical Product Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。